MedPath

ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP

ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP

Dormant
DIN Number

01960865

Drug Class

Human

Market Date

Oct 17, 1996

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01960865
AIG Number0514462001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.04.92
Health Canada Classification

ACTIVE INGREDIENTS (5)

ADENINEActive
Strength: 17.3 MG / 63 ML
Monograph: ADENINE
CITRIC ACIDActive
Strength: 189 MG / 63 ML
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 2 G / 63 ML
Monograph: DEXTROSE
SODIUM CITRATEActive
Strength: 1.66 G / 63 ML
Monograph: SODIUM CITRATE
SODIUM PHOSPHATE MONOBASICActive
Strength: 140 MG / 63 ML
Monograph: SODIUM PHOSPHATE MONOBASIC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.